Laddar...
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...
Sparad:
| I publikationen: | J Breast Cancer |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Korean Breast Cancer Society
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053309/ https://ncbi.nlm.nih.gov/pubmed/27721874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.3.252 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|